Screening and Monitoring
Cross-source consensus on Screening and Monitoring from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Comparisons
Evidence quality
Highlighted claims
- Routine vitamin B12 screening in long-term metformin users was uncommon across the evidence. — Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review
- Annual testing rates were generally below 20% of eligible patients. — Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review
- B12 screening was usually reactive to symptoms rather than preventive in known high-risk patients. — Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review
- Delayed testing may postpone diagnosis, especially for asymptomatic patients and older adults. — Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review